AXIM BIOTECHNOLOGIES, INC. (15) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Asset Purchase Agreement dated August 26, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC (Filed With SEC on April 15, 2022)
Binding Term Sheet Agreement dated August 3, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC (Filed With SEC on April 15, 2022)
PROMISSORY NOTE (Filed With SEC on February 16, 2022)
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on December 17, 2019)
CONVERTIBLE NOTE (Filed With SEC on February 16, 2022)
AXIM BIOTECHNOLOGIES, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 29, 2022 (Filed With SEC on February 16, 2022)
EQUITY PURCHASE AGREEMENT (Filed With SEC on May 14, 2021)
EQUITY PURCHASE AGREEMENT (Filed With SEC on May 14, 2021)
PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on February 26, 2019)